Swedish Orphan Biovitrum - Dividend History | BIOVF
Historical dividend payout and yield for Swedish Orphan Biovitrum (BIOVF) since 1971. The current TTM dividend payout for Swedish Orphan Biovitrum (BIOVF) as of December 31, 1969 is $0.00. The current dividend yield for Swedish Orphan Biovitrum as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.189B |
$2.086B |
|
Swedish Orphan Biovitrum is a biotechnology company. It develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company's product portfolio consists of Core Products segment which offers pharmaceuticals within Inflammation area and Genetics and metabolic therapeutic area; Partner Products segment which offers pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The company operates primarily in Sweden, Denmark, Finland, Norway, United Kingdom and France. Swedish Orphan Biovitrum is based in Solna, Sweden.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
